L3 skeletal muscle index (L3SMI) is a surrogate marker of sarcopenia and frailty in non-small cell lung cancer patients

Background: Non-small cell lung cancer (NSCLC) is a common and highly lethal disease. As advanced treatment modalities are being developed, improved prognostication methods are sought. L3 skeletal muscle index (L3SMI) and alanine aminotransferase (ALT) levels are accepted surrogate markers of sarcop...

Descripción completa

Detalles Bibliográficos
Autores principales: Portal, D, Hofstetter, L, Eshed, I, Dan-Lantsman, C, Sella, T, Urban, D, Onn, A, Bar, J, Segal, G
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove 2019
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6497853/
https://www.ncbi.nlm.nih.gov/pubmed/31114324
http://dx.doi.org/10.2147/CMAR.S195869

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6497853/
https://www.ncbi.nlm.nih.gov/pubmed/31114324
http://dx.doi.org/10.2147/CMAR.S195869

Ejemplares similares